Advanced search
Publication Cover
Clinical Ophthalmology Volume 6, 2012 - Issue
Submit an article Journal homepage
58
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from β-blockers and prostaglandin analogs

Kenji Inoue1 Inouye Eye Hospital, Chiyoda-ku, Tokyo, JapanCorrespondence[email protected]
,
Akira Setogawa1 Inouye Eye Hospital, Chiyoda-ku, Tokyo, Japan
,
Risako Higa1 Inouye Eye Hospital, Chiyoda-ku, Tokyo, Japan
,
Ryo Moriyama1 Inouye Eye Hospital, Chiyoda-ku, Tokyo, Japan
,
Masato Wakakura1 Inouye Eye Hospital, Chiyoda-ku, Tokyo, Japan
&
Goji Tomita2 2nd Department of Ophthalmology, Toho University School of Medicine, Tokyo, Japan
Pages 231-235 | Published online: 10 Feb 2012

References

  • DjafariFLeskMRHarasymowyczPJDesjardinsDLachaineJDeterminants of adherence to glaucoma medical therapy in long-term patient populationJ Glaucoma200918323824319295380
  • RheeDJPeaceJHMallickSLandryTABergaminiMVWthe study groupA study of the safety and efficacy of travoprost 0.004%/ timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol20082231331919668722
  • ArendKORaberTObservational study results in glaucoma patients undergoing a regimen replacement to fixed combination travoprost 0.004%/timolol 0.5% in GermanyJ Ocul Pharmacol Ther200824441442018665813
  • RossiGCPasinettiGMBracchinoMSwitching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort studyExpert Opin Pharmocother2009101117051711
  • ScherzerMLLiehneovaINegreteFJSchnoberDTravoprost 0.004%/ timolol 0.5% fixed combination in patients transitioning fixed or unifixed bimatoprost 0.03%/timolol 0.5%Adv Ther201128866167021773673
  • SchumanJSKatzGJLewisRAEfficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertensionAm J Ophthalmol2005140224225016086946
  • HughesBABacharachJCravenERA three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/ timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertensionJ Glaucoma200514539239916148589
  • BarnebeyHSOrengo-naniaSFlowersBEThe safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solutionAm J Ophthalmol200514011715990081
  • DunkerSSchmuckerAMaierHLatanoprost/timolol fixed combination study groupTolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timololAdv Ther200724237638617565929
  • InoueKOkayamaRHigaRSawadaHWakakuraMTomitaGOcular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol 0.5% fixed combinationJ Ocul Pharmacol Ther201127658158722011049

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.